Literature DB >> 3127399

Mitomycin C-induced organ toxicity in Wistar rats: a study with special focus on the kidney.

J Verweij1, S Kerpel-Fronius, M Stuurman, A J van Triet, L van Hattum, J de Vries, H M Pinedo.   

Abstract

Two studies were performed to investigate acute and chronic organ toxicity after Mitomycin C (MMC) administration in Wistar rats. Six rats received 2.5 mg/kg MMC i.p. once and were followed for 5 consecutive days. The alanine aminopeptidase (AAP)/creatinine ratio increased significantly, compared to a control group receiving saline. Four groups of rats were injected i.p. weekly for 5 weeks; 6 control rats with saline, 7 rats with 1.7 mg/kg of MMC, 7 rats with 10 mg/kg 5-fluorouracil (5-FU) and 7 rats with MMC as well as 5-FU. The latter two groups were included to study possible toxicity synergism between the two drugs. A significant decrease in AAP excretion in the MMC group, as well as a nonsignificant decrease in the MMC/5-FU group were the most remarkable observations. Light microscopy did not show renal changes, but did not show alveolar septal congestion after repeated MMC injections. It is concluded that MMC causes tubular damage in Wistar rats, with acute leakage of enzyme from the cells, followed by enzyme depletion during chronic treatment. Also MMC induces pulmonary changes in Wistar rats. To what extent these changes represent early stages of toxicity remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3127399     DOI: 10.1007/bf00417827

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  [A FLUORIMETRIC ULTRAMICROMETHOD FOR DETERMINATION OF LEUCINE AMINOPEPTIDASE IN BIOLOGICAL FLUIDS].

Authors:  M ROTH
Journal:  Clin Chim Acta       Date:  1964-05       Impact factor: 3.786

2.  BIOLOGICAL STUDIES OF ANTICANCER AGENTS. I. EFFECTS OF PROLONGED INTRAPERITONEAL INJECTIONS OF MITOMYCIN C ON THE URINARY ORGANS.

Authors:  M MATSUYAMA; K SUZUMORI; T NAKAMURA
Journal:  J Urol       Date:  1964-12       Impact factor: 7.450

3.  Pharmacology of mitomycin C. I. Toxicity and pathologic effects.

Authors:  F S PHILIPS; H S SCHWARTZ; S S STERNBERG
Journal:  Cancer Res       Date:  1960-10       Impact factor: 12.701

4.  Enzymes in renal diseases.

Authors:  H Mattenheimer
Journal:  Ann Clin Lab Sci       Date:  1977 Sep-Oct       Impact factor: 1.256

5.  [Diagnostic value of urinary enzyme determination].

Authors:  U Burchardt; J E Peters; L Neef; H Thulin; C A Gründig; R J Haschen
Journal:  Z Med Lab Diagn       Date:  1977-06

6.  Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.

Authors:  J M Wellwood; B G Ellis; R G Price; K Hammond; A E Thompson; N F Jones
Journal:  Br Med J       Date:  1975-08-16

7.  Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.

Authors:  U Diener; E Knoll; B Langer; H Rautenstrauch; D Ratge; H Wisser
Journal:  Clin Chim Acta       Date:  1981-05-05       Impact factor: 3.786

8.  The diagnostic value of urinary enzyme measurements in hypertension.

Authors:  I D Johnston; N F Jones; J E Scoble; C T Yuen; R G Price
Journal:  Clin Chim Acta       Date:  1983-10-14       Impact factor: 3.786

9.  N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.

Authors:  R L Sherman; D E Drayer; B R Leyland-Jones; M M Reidenberg
Journal:  Arch Intern Med       Date:  1983-06

10.  Adriamycin and mitomycin C: possible synergistic cardiotoxicity.

Authors:  A U Buzdar; S S Legha; C K Tashima; G N Hortobagyi; H Y Yap; A N Krutchik; M A Luna; G R Blumenschein
Journal:  Cancer Treat Rep       Date:  1978-07
View more
  3 in total

1.  The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse.

Authors:  Gemma Molyneux; Frances M Gibson; Edward C Gordon-Smith; Andrew M Pilling; Kai Chiu Liu; Sian Rizzo; Susan Sulsh; John A Turton
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

2.  Engraftment of syngeneic and allogeneic endothelial cells, hepatocytes and cholangiocytes into partially hepatectomized rats previously treated with mitomycin C.

Authors:  Kate E Brilliant; David R Mills; Helen M Callanan; Douglas C Hixson
Journal:  Transplantation       Date:  2009-08-27       Impact factor: 4.939

3.  A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C.

Authors:  J Verweij; A J Funke-Küpper; G J Teule; H M Pinedo
Journal:  Med Oncol Tumor Pharmacother       Date:  1988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.